Abstract
BACKGROUND: Oral anticoagulants (OACs) are recommended for nonvalvular atrial fibrillation (NVAF) patients with moderate-to high-stroke risk. OBJECTIV......
小提示:本篇文献需要登录阅读全文,点击跳转登录